Table 1 Abnormal values and values within normal ranges of serum anti-OmpC IgA (>25U/mL vs. <20U/mL), anti-GP2 IgG (>20U/mL vs. <15U/mL) and anti-GP2 IgA (>20U/mL vs. <15U/mL) in controls, CD patients and UC patients
controls | CD | UC | |
|---|---|---|---|
Anti-OmpC IgA >25U/mL | 8/45 (18%) | 53/86 (62%) | 13/25 (52%) |
Anti-OmpC IgA <20U/mL | 26/45 (58%) | 22/86 (26%) | 6/25 (24%) |
Anti-GP2 IgG >20U/mL | 1/45 (2%) | 27/86 (31%) | 4/25 (16%) |
Anti-GP2 IgG <15U/mL | 42/45 (93%) | 49/86 (57%) | 21/25 (84%) |
Anti-GP2 IgA >20U/mL | 8/45 (18%) | 43/86 (50%) | 2/25 (8%) |
Anti-GP2 IgA <15U/mL | 33/45 (73%) | 35/86 (41%) | 21/25 (84%) |
Sens/Spec/NPV/PPV of anti-OmpC IgA [%] | 71/76/54/87 | 68/76/81/62 | |
Sens/Spec/NPV/PPV of anti-GP2 IgG [%] | 36/98/47/96 | 16/98/67/80 | |
Sens/Spec/NPV/PPV of anti-GP2 IgA [%] | 55/80/49/84 | 9/80/61/20 |